FDA schválil první biosimilární přípravek v USA
Authors:
E. Srbová
Authors‘ workplace:
redakce Zdravotnických novin, Praha
Published in:
Klin Onkol 2015; 28(2): 142
Category:
Oncology Highlights
Tato aktualita byla podpořena firmou Sandoz.
Overview
Submitted:
26. 3. 2015
Labels
Paediatric clinical oncology Surgery Clinical oncologyArticle was published in
Clinical Oncology
2015 Issue 2
- The Benefit of Liposomal Irinotecan in the Treatment of Pancreatic Cancer in a Young Patient – A Case Study
- Doc. Jiří Kubeš: The major benefit of proton therapy lies in protecting healthy tissues
- Minimally Invasive Treatment of Pilonidal Sinus: Laser and Negative Pressure Therapy as a Gentle and Effective Modality
- Invasive Pulmonary Aspergillosis – A Common Accompanying Infection in Patients with Severe or Critical Course of COVID-19
Most read in this issue
- Malignant Tumors of Thyroid Gland
- Vitamin D During Cancer Treatment
- Glomus Tumor of the Finger – Case Report
- The Importance of Early Tumor Shrinkage and Deepness of Response in Assessing the Efficacy of Systemic Anticancer Treatment with Metastatic Colorectal Cancer